Keyphrases
Resection
100%
Alpha-fetoprotein
100%
Hepatocellular Carcinoma Recurrence
100%
Total Tumor Volume
100%
Recurrence Prediction
100%
Hepatocellular Carcinoma
36%
Volume Ratio
36%
Post-resection
18%
Peak alpha
18%
Retrospective Cohort Study
9%
Tumor
9%
United States
9%
Tertiary Care Hospital
9%
Working Diagnosis
9%
Multivariate Analysis
9%
Liver Disease
9%
Large Series
9%
5-year Survival
9%
Consecutive Patients
9%
Disease-free Survival
9%
Tumor Volume
9%
Patient Demographics
9%
Surgical Pathology
9%
Intraoperative Imaging
9%
Before Surgery
9%
MELD Score
9%
Lymphovascular Invasion
9%
3-year Survival
9%
Mean Radius
9%
Prognostic Indicator
9%
Child-Pugh
9%
East Asia
9%
Hepatocellular Disease
9%
Child Model
9%
East Asian Studies
9%
Medicine and Dentistry
Neoplasm
100%
Hepatocellular Carcinoma
100%
Recurrent Disease
100%
Alpha-Fetoprotein
100%
Surgery
100%
Liver Disease
9%
Retrospective Cohort Study
9%
Multivariate Analysis
9%
Lymph Duct
9%
Disease Free Survival
9%
Model For End Stage Liver Disease Score
9%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Liver Cell Carcinoma
100%
Recurrent Disease
100%
Alpha Fetoprotein
100%
Cohort Study
9%
Liver Disease
9%
Disease Free Survival
9%
End Stage Liver Disease
9%